Volume 20, Number 4—April 2014
Research
Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
Table 1
Complication | No. MMR doses received by case-patient | No. (%) case-patients with complications | Crude OR (95% CI) | p value | aOR† (95%CI) | p value | aVE† (95% CI) |
---|---|---|---|---|---|---|---|
Orchitis§ | 0 | 36 (15.5) | Ref | Ref | Ref | Ref | |
1 | 10 (6.6) | 0.46 (0.22–0.97) | 0.04 | 0.46 (0.22–0.98) | 0.04 | 54 (2–78) | |
2 | 46 (4.7) | 0.26 (0.16–0.41) | <0.01 | 0.26 (0.15–0.43) | <0.01 | 74 (57–85) | |
Deafness | 0 | 2 (0.9) | Ref | ||||
1 | 0 | NA | NA | – | – | – | |
2 | 1 (0.1) | 0.12 (0.01–1.3) | 0.1 | – | – | – | |
Meningitis | 0 | 2 (0.8) | Ref | ||||
1 | 1 (0.6) | 0.76 (0.07–8.5) | 0.8 | – | – | – | |
2 | 2 (0.2) | 0.24 (0.03–1.7) | 0.2 | – | – | – | |
All complications | 0 | 44 (19.0) | Ref | Ref | Ref | Ref | |
1 | 10 (6.6) | 0.30 (0.15–0.62) | <0.01 | 0.29 (0.14–0.62) | <0.01 | 71 (38–86) | |
2 | 55 (5.7) | 0.26 (0.17–0.39) | <0.01 | 0.24 (0.14–0.39) | <0.01 | 76 (61–86) | |
Hospitalization | 0 | 11 (4.8) | Ref | Ref | Ref | Ref | |
1 | 3 (2.0) | 0.41 (0.11–1.5) | 0.18 | 0.43 (0.11–1.6) | 0.2 | 57 (–60 to 89) | |
2 | 10 (1.1) | 0.22 (0.09–0.52) | <0.01 | 0.18 (0.07–0.47) | <0.01 | 82 (53–93) |
*Only case-patients with known complications and vaccination status were included in the analyses. OR, odds ratio; VE, vaccine effectiveness; Ref, referent; NA, not applicable; –, not analyzed (insufficient sample size).
†Adjusted for age (age groups <18 y, 18–25 y, >25 y) and sex, except orchitis, which was adjusted only for age.
§Includes only male case-patients >12 y of age.
Page created: March 12, 2014
Page updated: March 12, 2014
Page reviewed: March 12, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.